Dr. Stephen Scelsa, MD

Dr. Scelsa practices at Mount Sinai - Brooklyn in Brooklyn, New York.

Dr. Scelsa's NPI, 1770574980, was assigned on November 4, 2005. Dr. Scelsa graduated from SUNY Downstate Health Sciences University in 1988. Dr. Scelsa holds New York license 179928.

Dr. Scelsa's primary practice is Mount Sinai - Brooklyn, at 3201 Kings Hwy, Brooklyn, NY 11234 in Kings County. The practice phone is (646) 605-6009.

Dr. Scelsa's primary practice is Mount Sinai - Brooklyn in Brooklyn, New York. Dr. Scelsa is also affiliated with The Mount Sinai Hospital. The medical group on file is Mount Sinai Institute for Liver Medicine. Dmand AI also links Dr. Scelsa to 3 more hospitals, 1 group practice or clinic, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Scelsa practices, 6 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Scelsa's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Scelsa is board certified in clinical neurophysiology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Scelsa's licenses on file in 2 states: New York and Florida.

Dmand AI lists alzheimer's disease, carpal tunnel syndrome, fibromyalgia and chronic pain, hereditary polyneuropathy, lower back pain, muscle disease, muscle pain, fibromyalgia, and limb pain and neck pain and spine problems among the conditions Dr. Scelsa treats.

CMS data shows 797 Medicare services from Dr. Scelsa across 16 procedure codes in 2024, for 236 Medicare patients. Medicare paid $52,893 for them. Every service was in an office.

CMS counts 236 Medicare patients who saw Dr. Scelsa in 2024. The largest group is 65 to 74, with 100 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 25% are also on Medicaid. Their average risk score is 1.57, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Scelsa's median patient age at 62, with 55% women.

In 2024, Dr. Scelsa wrote 2,323 Medicare Part D claims for 275 patients. 79% of them were for generic drugs. CMS names the drug for 2,104 of them, across 37 drugs with 11 or more claims each, at $4,756,068 in total drug cost. In 2023, CMS named 1,953 claims across 31 drugs.

Dr. Scelsa accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Scelsa as offering telehealth.

Dmand AI links 45 papers to Dr. Scelsa, published from 2009 to 2025. 2020 was the busiest year, with 3. The most frequent topics are Amyotrophic Lateral Sclerosis, Electromyography and Neural Conduction. Dr. Scelsa has published most often in Muscle Nerve. Dr. Scelsa's most frequent co-authors are Alan Ross Berger, MD, Christina Nicole Fournier, MD and Daragh Heitzman, MD.

Dmand AI links Dr. Scelsa to 2 clinical trials. Conditions studied include Agnosia, Amyotrophic Lateral Sclerosis and Perceptual Disorders.

CMS Open Payments shows 3 general payments to Dr. Scelsa from 2 drug and device companies in 2018. Travel and lodging make up the largest share, 61% of the total. Orion Corporation paid the most, $1,719.

Dr. Scelsa graduated from SUNY Downstate Health Sciences University in 1988. Dr. Scelsa is a member of AAN.

Dr. Scelsa is in network with 16 carriers, including Elevance, Aetna and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.